709 related articles for article (PubMed ID: 28506438)
1. Prion-like Spreading in Tauopathies.
Ayers JI; Giasson BI; Borchelt DR
Biol Psychiatry; 2018 Feb; 83(4):337-346. PubMed ID: 28506438
[TBL] [Abstract][Full Text] [Related]
2. Populations of Tau Conformers Drive Prion-like Strain Effects in Alzheimer's Disease and Related Dementias.
Hromadkova L; Siddiqi MK; Liu H; Safar JG
Cells; 2022 Sep; 11(19):. PubMed ID: 36230957
[TBL] [Abstract][Full Text] [Related]
3. Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain.
Narasimhan S; Guo JL; Changolkar L; Stieber A; McBride JD; Silva LV; He Z; Zhang B; Gathagan RJ; Trojanowski JQ; Lee VMY
J Neurosci; 2017 Nov; 37(47):11406-11423. PubMed ID: 29054878
[TBL] [Abstract][Full Text] [Related]
4. Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice.
Stancu IC; Vasconcelos B; Ris L; Wang P; Villers A; Peeraer E; Buist A; Terwel D; Baatsen P; Oyelami T; Pierrot N; Casteels C; Bormans G; Kienlen-Campard P; Octave JN; Moechars D; Dewachter I
Acta Neuropathol; 2015 Jun; 129(6):875-94. PubMed ID: 25862635
[TBL] [Abstract][Full Text] [Related]
5. Molecular Mechanisms in the Pathogenesis of Alzheimer's disease and Tauopathies-Prion-Like Seeded Aggregation and Phosphorylation.
Hasegawa M
Biomolecules; 2016 Apr; 6(2):. PubMed ID: 27136595
[TBL] [Abstract][Full Text] [Related]
6. Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies.
Strang KH; Croft CL; Sorrentino ZA; Chakrabarty P; Golde TE; Giasson BI
J Biol Chem; 2018 Feb; 293(7):2408-2421. PubMed ID: 29259137
[TBL] [Abstract][Full Text] [Related]
7. Prion-like strain effects in tauopathies.
Han ZZ; Kang SG; Arce L; Westaway D
Cell Tissue Res; 2023 Apr; 392(1):179-199. PubMed ID: 35460367
[TBL] [Abstract][Full Text] [Related]
8. Human tauopathy-derived tau strains determine the substrates recruited for templated amplification.
Tarutani A; Miyata H; Nonaka T; Hasegawa K; Yoshida M; Saito Y; Murayama S; Robinson AC; Mann DMA; Tomita T; Hasegawa M
Brain; 2021 Sep; 144(8):2333-2348. PubMed ID: 33693528
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of Cell-to-Cell Transmission of Pathological Tau: A Review.
Gibbons GS; Lee VMY; Trojanowski JQ
JAMA Neurol; 2019 Jan; 76(1):101-108. PubMed ID: 30193298
[TBL] [Abstract][Full Text] [Related]
10. Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
Lewis J; Dickson DW
Acta Neuropathol; 2016 Jan; 131(1):27-48. PubMed ID: 26576562
[TBL] [Abstract][Full Text] [Related]
11. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
[TBL] [Abstract][Full Text] [Related]
12. Invited review: Prion-like transmission and spreading of tau pathology.
Clavaguera F; Hench J; Goedert M; Tolnay M
Neuropathol Appl Neurobiol; 2015 Feb; 41(1):47-58. PubMed ID: 25399729
[TBL] [Abstract][Full Text] [Related]
13. Tau strains shape disease.
Vaquer-Alicea J; Diamond MI; Joachimiak LA
Acta Neuropathol; 2021 Jul; 142(1):57-71. PubMed ID: 33830330
[TBL] [Abstract][Full Text] [Related]
14. Tauopathies as clinicopathological entities.
Irwin DJ
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(0 1):S29-33. PubMed ID: 26382841
[TBL] [Abstract][Full Text] [Related]
15. Frontotemporal dementia with tau pathology.
Gasparini L; Terni B; Spillantini MG
Neurodegener Dis; 2007; 4(2-3):236-53. PubMed ID: 17596718
[TBL] [Abstract][Full Text] [Related]
16. Tau exhibits unique seeding properties in globular glial tauopathy.
Chung DC; Carlomagno Y; Cook CN; Jansen-West K; Daughrity L; Lewis-Tuffin LJ; Castanedes-Casey M; DeTure M; Dickson DW; Petrucelli L
Acta Neuropathol Commun; 2019 Mar; 7(1):36. PubMed ID: 30845985
[TBL] [Abstract][Full Text] [Related]
17. Cellular and pathological heterogeneity of primary tauopathies.
Chung DC; Roemer S; Petrucelli L; Dickson DW
Mol Neurodegener; 2021 Aug; 16(1):57. PubMed ID: 34425874
[TBL] [Abstract][Full Text] [Related]
18. The Prion-Like Behavior of Assembled Tau in Transgenic Mice.
Clavaguera F; Tolnay M; Goedert M
Cold Spring Harb Perspect Med; 2017 Oct; 7(10):. PubMed ID: 27940600
[TBL] [Abstract][Full Text] [Related]
19. Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo.
Kaufman SK; Sanders DW; Thomas TL; Ruchinskas AJ; Vaquer-Alicea J; Sharma AM; Miller TM; Diamond MI
Neuron; 2016 Nov; 92(4):796-812. PubMed ID: 27974162
[TBL] [Abstract][Full Text] [Related]
20. Towards a Mechanistic Model of Tau-Mediated Pathology in Tauopathies: What Can We Learn from Cell-Based In Vitro Assays?
Sala-Jarque J; Zimkowska K; Ávila J; Ferrer I; Del Río JA
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
